ctrl K

Price Alert

DiaMedica Therapeutics In... (DMAC)

NASDAQ: DMAC · Real-Time Price · USD

5.76

0.00 (0.00%)

At close: Aug 19, 2025, 3:59 PM

5.77

0.09%

After-hours: Aug 19, 2025, 04:10 PM EDT

DiaMedica Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.02M	4.54M	4.73M	4.71M
Short-Term Investments	41.12M	48.35M	28.77M	40.41M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.31M	n/a	n/a	n/a
Receivables	236K	369K	82K	130K
Inventory	n/a	n/a	n/a	113K
Other Current Assets	227K	n/a	n/a	-113K
Total Current Assets	44.61M	53.67M	33.84M	45.44M
Property-Plant & Equipment	427K	485K	560K	112K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.74M	485K	560K	112K
Total Assets	46.34M	54.16M	34.4M	45.55M
Account Payables	940K	926K	734K	509K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	83K	69K	49K
Other Current Liabilities	4.35M	-83K	629K	435K
Total Current Liabilities	5.39M	2.79M	2.17M	1.52M
Long-Term Debt	n/a	317K	400K	3K
Other Long-Term Liabilities	n/a	-317K	-400K	-3K
Total Long-Term Liabilities	237K	317K	400K	3K
Total Liabilities	5.63M	3.1M	2.57M	1.53M
Total Debt	340K	400K	469K	52K
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-140M	-115.56M	-96.18M	-82.5M
Comprehensive Income	23K	6K	-74K	-51K
Shareholders Equity	40.72M	51.06M	31.83M	44.02M
Total Investments	41.12M	48.35M	28.77M	40.41M